Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Non-Current Assets (2021 - 2025)

Historic Non-Current Assets for Core Scientific (CORZ) over the last 5 years, with Q3 2025 value amounting to $1.2 billion.

  • Core Scientific's Non-Current Assets rose 9176.34% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $3.7 billion, marking a year-over-year increase of 4359.68%. This contributed to the annual value of $694.9 million for FY2024, which is 1295.85% up from last year.
  • As of Q3 2025, Core Scientific's Non-Current Assets stood at $1.2 billion, which was up 9176.34% from $973.3 million recorded in Q2 2025.
  • Over the past 5 years, Core Scientific's Non-Current Assets peaked at $1.9 billion during Q1 2022, and registered a low of $345.0 million during Q1 2021.
  • Its 5-year average for Non-Current Assets is $842.0 million, with a median of $670.6 million in 2024.
  • In the last 5 years, Core Scientific's Non-Current Assets soared by 44949.17% in 2022 and then crashed by 6519.55% in 2023.
  • Over the past 5 years, Core Scientific's Non-Current Assets (Quarter) stood at $1.7 billion in 2021, then plummeted by 57.05% to $722.6 million in 2022, then fell by 14.87% to $615.1 million in 2023, then grew by 12.96% to $694.9 million in 2024, then soared by 77.73% to $1.2 billion in 2025.
  • Its Non-Current Assets stands at $1.2 billion for Q3 2025, versus $973.3 million for Q2 2025 and $792.2 million for Q1 2025.